AIVF

Find the latest for AIVF company news

Disrupting Tradition, AIXOR Launches Genesis AI Pro 5.0 to Lead the Intelligent Trading Revolution

The core technological advantage of AIXOR Exchange is embodied in its brand-new AI trading system-Genesis AI Pro 5.0. As an industry-leading AI-driven trading technology, Genesis AI Pro 5.0 features three core breakthroughs: - Adaptive to Market Changes, Smartly Optimizing Trading Strategies

Blockchain 7month
AI meets oncology: New model personalizes bladder cancer treatment

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more effective model for predicting how patients with muscle-invasive bladder cancer will respond to chemotherapy.

Upholding Ethics, Fast-Tracking Science: Experts Weigh In on Balancing Innovation in the IVF Revolution

As reproductive technologies evolve, innovations like CRISPR gene editing, artificial wombs, and AI-driven embryo selection offer hope for higher IVF success rates and genetic disorder prevention. However,

Anduril Teams with Microsoft to Advance IVAS Program for U.S. Army

Anduril and Microsoft partner to advance the IVAS program, delivering next-gen AR/VR and AI capabilities to the US Army, enhancing battlefield awareness and mission command.

Aiforia Technologies Oyj: Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology

Aiforia and Techcyte announce strategic collaboration to advance AI-powered digital pathology Aiforia Technologies Plc, Press Release, March 21, 2025 at 09:00 a.m. EET Aiforia, a trusted provider of d

The tensions underlying AI and IVF

As with fears over the expansion of artificial intelligence, human choice holds a primary role in tensions surrounding the regulation of in vitro fertilization. A certain pessimism motivates both.

Viant Technology Inc. (DSP) Reports Record Q4 2024, Driven by ViantAI Innovations

We recently published a list of 9 AI News Updates Investors Should Not Miss. In this article, we are going to take a look at where Viant Technology Inc. (NASDAQ:DSP) stands against other AI news updates investors should not miss.

AI accelerating medical research; Solving pain points in sales

Beyond speed, AI has also helped reduce costs. Conventional methods required nearly $35,000 per genome analysis, but AI-driven models running on GPUs have lowered the cost to under $2,000, making high-quality genomic research more accessible.

AI hardware 8month